Experimental data displayed that bone marrow samples of subjects with active MM evidence remarkably greater concentrations of AQP1 with respect to those from subjects with non-active MM, whose concentrations are increased, but to a lower level, than those of subjects affected by monoclonal gammopathies of undetermined significance (MGUS). The gene discussed is AQP1; the disease is Miyoshi myopathy.